HealthQuill European Commission
The European Commission has approved Vertex Pharmaceuticals' drug to treat cystic fibrosis in adults and children above six years of age who have certain genetic mutations related to the disease.
Drugs Health Pharma

EC approves Vertex’s once-daily drug combination to treat cystic fibrosis 

HQ Team July 3, 2025:  The European Commission has approved Vertex Pharmaceuticals‘ drug to treat cystic fibrosis in adults and children above six.

Read More
World leaders have pledged $9 billion to support Gavi, the Vaccine Alliance, for the next five years after the US administration terminated its funding, arguing the organisation did not take vaccine safety seriously.
Drugs Health Medical

Gavi, the Vaccine Alliance, secures $9 billion funding from global donors

HQ Team June 28, 2025: World leaders have pledged $9 billion to support Gavi, the Vaccine Alliance, for the next five years after.

Read More
The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating thyroid eye disease, according to a statement.
Drugs Medical Pharma

Amgen’s thyroid eye disease medicine gets EU market authorisation

HQ Team April 27, 2025: The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating.

Read More
Merck & Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours, and who had prior treatment, has been “conditionally” approved by the European Commission, according to a company statement.
Drugs Health Medical

EC grants ‘conditional’ nod for Merck’s drug to treat VHL disease

HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.

Read More
Atara Biotherapeutics’ Ebvallotm therapy, for treating patients with a rare cancer that occurs after stem cell transplantation, got rejected by the US drug regulator.
Drugs Health Pharma

US drug regulator rejects Atara Biotherapeutics’ rare cancer therapy

Atara Biotherapeutics’ Ebvallotm therapy, for treating patients with a rare cancer that occurs after stem cell transplantation, got rejected by the US drug.

Read More
The European Union regulators have greenlighted AstraZeneca’s drug to treat an advanced form of non-small cell lung cancer after it reduced the death rate by 84%.
Drugs Medical Pharma

EU greenlights AstraZeneca’s non-small cell lung cancer drug

The European Union regulators have greenlighted AstraZeneca’s drug to treat an advanced form of non-small cell lung cancer after it reduced the death.

Read More
Merck & Co., got approval from the European Commission to market its combination therapy to treat metastatic urothelial cancer or bladder cancer in 27 member states and other nations.
Drugs Health Pharma

EC approves Merck’s bladder cancer combination therapy in adults 

Merck & Co., got approval from the European Commission to market its combination therapy to treat metastatic urothelial cancer or bladder cancer in.

Read More
Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus vaccine from CSL Sequris UK Ltd., over a maximum period of four years to prevent the spread or potential outbreaks of bird flu in the region.
Drugs Health Pharma

EU to procure 40 million doses of avian flu vaccine from CSL Seqirus 

Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus.

Read More
The European Commission has granted marketing approval for Biogen Inc.’s therapy for the treatment of a form of amyotrophic lateral sclerosis.
Drugs Health Pharma

Biogen’s ALS drug gets European Commission’s marketing nod

The European Commission has granted marketing approval for Biogen Inc.’s therapy for the treatment of a form of amyotrophic lateral sclerosis.

Read More
Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance Minister Bruno Le Maire said, according to a publicly-funded television network, France 24.
Drugs Health Pharma

Pfizer, AstraZeneca to invest close to $1 billion in France to expand

HQ Team May 13, 2024: Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance.

Read More